Pro members get same-minute coverage on the stocks they track. Free plans update twice a day.
Get ProCounts of positive, neutral, and negative news items. Not a price chart.
Informational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.
Showing 4 stories from June 2026
Show allThe items moving the net sentiment the most, by direction and influence.
Dr. Reddy's Hyderabad Biologics Plant Receives 7 USFDA Observations, Raising Supply Risk
US FDA / USFDA · Medium influence · Short term
US Cancer Drug Shortage Creates Generic Supply Window for Sun Pharma and Dr Reddy's
US FDA / USFDA · Medium influence · Short term
Dr Reddy's Biologics Site Gets 7 USFDA Observations After Pre-License Inspection
Direct news · Low influence · Short term
Dr. Reddy's Hits 52-Week High Despite USFDA Observations as Biologics Pipeline Offsets Regulatory Overhang
US FDA / USFDA · Medium influence · Short term
Macro, commodity, FX and regulatory forces that moved DRREDDY in this range, with the stories behind each.
Sign up free to track DRREDDY, unlock full history and the complete driver breakdown, and get alerts when sentiment shifts.
Track DRREDDY for freeInformational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.
Also monitored for DRREDDY (no news in this range): Indian rupee / INR-USD.
How news sentiment on Dr. Reddy's Laboratories Ltd. (DRREDDY) has built up over time. Each bar sums the direction of every story TradeTidings published in the period, weighted by how influential we rated it, not just a plain count, so a single high-influence negative story can outweigh several small positive ones. Hover a bar for its exact figures, or click one to filter the stories below to that period. Our own original analysis, not a copied index or a price chart, and not a prediction.
